Skip to main content
. Author manuscript; available in PMC: 2019 Sep 16.
Published in final edited form as: Curr Pharm Des. 2017 Nov 16;23(29):4226–4246. doi: 10.2174/1381612823666170616082125

Table 4.

Targeted therapy for Src

Inhibitor Target Types of cancer
BMS-354825 (Dasatinib) [6772] Src
Bcr-Abl
PDGFR
c-Kit
EphA2
HR/HER2-positive breast cancer, triple-negative breast cancer, castration-resistant prostate cancer, NSCLC, colon cancer, HNSCC metastatic breast cancer, myeloid leukemia
AZD0530 (Saracatinib) [73] Src
Bcr-Abl
castration-resistant prostate cancer
SKI-606 (Bosutinib) [7478] Src
Bcr-Abl
Myeloid leukemia, metastatic breast cancer